L V Prasad Eye Institute

What L V Prasad Eye Institute does

L V Prasad Eye Institute (LVPEI) is a not-for-profit comprehensive eye care institution headquartered at the Kallam Anji Reddy Campus in Banjara Hills, Hyderabad, India, with regional tertiary campuses in Visakhapatnam (GMR Varalakshmi Campus, 2006), Vijayawada (Kode Venkatadri Chowdary Campus, 2011), Bhubaneswar (Mithu Tulsi Chanrai Campus), Kadapa (Rajasekhara Reddy Campus, 2024), and an international presence through the Liberia Eye Center at JFK Medical Centre, Monrovia (since 2016). The institute operates a pyramidal service delivery model of more than 316 eye care centres that escalates from primary Vision Centres through secondary and tertiary facilities to a quaternary institute, supported by community screenings, school vision programmes, LVPEI@Home home-based services, and the LVPEI Connect online consultation app. Patient volumes exceed 2.6 million services and 200,000 surgeries annually, with cumulative patient visits surpassing 25.9 million since 1987, and 50% of services delivered at no cost to patients.

LVPEI's technology and capability stack spans clinical care across all major ophthalmic subspecialties (cataract, glaucoma, cornea, retina, pediatric ophthalmology, neuro-ophthalmology, oncology, and refractive surgery), vision rehabilitation, eye banking through the Asia-Pacific's largest eye bank (Ramayamma International Eye Bank, established 1989, with 113,128+ corneas harvested and 65,113+ utilized), an Ophthalmic Pathology Laboratory, an Eye and Brain Centre with a neuroscience and genetic testing laboratory, and a translational research programme producing publications in venues such as Communications Biology, Journal of Biological Chemistry, and Translational Vision Science and Technology. The institute is a designated WHO Collaborating Centre for the Prevention of Blindness and a SightLife Center of Excellence in Eye Banking, with NABH Eye Care Organization accreditations across campuses.

The business model combines cross-subsidized paid services, donations and grants from individual, corporate, and foundation donors (Cognizant Foundation, Standard Chartered, Infosys Foundation, ICICI Foundation, Mission for Vision, Microsoft, USAID, Lions Clubs International Foundation, Operation Eyesight Universal), and government partnerships, with 50% of services cross-subsidized to economically disadvantaged patients. Revenue figures are not publicly disclosed. LVPEI is governed as a trust/society under the leadership of Founder Chair Dr Gullapalli N Rao and Executive Chair Dr Prashant Garg, with an academic/research mandate that includes fellowship and residency training, tele-screening across 23 districts for retinopathy of prematurity, and capacity-building programmes for other eye care organizations through GPR ICARE.

Name

L V Prasad Eye Institute

Legal name

L V Prasad Eye Institute

Website

https://lvpei.org

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

501–1,000 employees

Short description

L V Prasad Eye Institute is a non-profit comprehensive eye health network operating 316 centres across Andhra Pradesh, Telangana, Odisha, Karnataka, and Liberia. It provides cataract, glaucoma, retina, pediatric, and neuro-ophthalmology services, with 50% delivered free through donor cross-subsidization.

Ownership category

akta.pro rank

Product category

Eye Care Services

NAICS

Offices of Optometrists (62132), Offices of Optometrists (621320), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Comprehensive Eye Exams & Vision Care (HLAKAKAA), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI), Ophthalmology Surgery Centers (HLAFAIAF)

Keywords

• Eye care services
• Ophthalmology hospital
• Vision rehabilitation
• Eye banking
• Community eye health

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Cross-subsidization model: Services are provided to patients regardless of ability to pay, with 50% of services provided at no cost. Revenue from paying patients cross-subsidizes free services for economically disadvantaged patients.
2. Donations and charitable contributions: The institute receives support from individual donors, corporate donors, and foundations to fund free services and expansion of eye care access.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

L V Prasad Eye Institute is a comprehensive not-for-profit eye care institution that delivers clinical ophthalmology services (cataract, glaucoma, cornea, retina, pediatric ophthalmology, neuro-ophthalmology, and oncology) through a pyramidal network of 316 centres. It runs the Asia-Pacific's largest eye bank, vision rehabilitation, community eye health programs, teleconsultation via LVPEI Connect, home-based care via LVPEI @Home, advanced ophthalmic education, and clinical/basic science research. 50% of services are provided at no cost through a cross-subsidization model.

Product overview

L V Prasad Eye Institute operates as a comprehensive eye health network offering integrated eye care services across clinical care, education, research, vision rehabilitation, community eye health, eye banking, advocacy, and capacity building. The institute's portfolio includes direct healthcare delivery through its pyramidal network model (LVPEI Connect for teleconsultations, LVPEI @Home for home-based care), the Ramayamma International Eye Bank for corneal transplants, research and education programs, and international operations through the Liberia Eye Centre. With 316 centres across Andhra Pradesh, Telangana, Odisha, and Karnataka, the institute provides services from primary vision centres to quaternary care, offering both in-person and digital consultation options. The institute also conducts community outreach programs, capacity building for other eye care organizations, and awareness campaigns like the annual Whitathon for retinoblastoma.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 91% of cataract surgery patients regain 6/12 vision or better
• +6 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

15 partnerships are on record, tiered major, minor and core.

• Hyderabad RunnersmajorGTM or Marketing Partner · 10 May 2026Hyderabad Runners are the Run Partner for Whitathon 2026. The eighth edition drew nearly 2,000 participants across four race categories.
• Alcon Laboratories (India) Pvt LtdmajorGTM or Marketing Partner · 10 May 2026Diamond Sponsor for Whitathon 2026 Hyderabad edition.
• EMRI Green Health ServicesminorGTM or Marketing Partner · 10 May 2026Medical Partner for Whitathon 2026.
• AIR VIVIDH Bharathi FMminorGTM or Marketing Partner · 10 May 2026Radio Partner for Whitathon 2026.
• Arclight Project / Tata TrustscoreStrategic or Co-development Partner · 21 April 2026Arclight Project supported by Tata Trusts partnered with LVPEI to equip frontline healthcare workers in aspirational districts (Kadapa, Alluri Seetharam Raju in Andhra Pradesh; Bhdradri Kothagudem in Telangana) with tools and skills to identify serious eye conditions early. Hosted Train-the-Trainer workshop with Dr Andrew Blaikie.
• Indian Institute of Technology Hyderabad (IIT-H)coreStrategic or Co-development Partner · 17 April 2026LVPEI received ICMR Centre for Advanced Research (CAR) funding for C-ARREST initiative - collaborative research on retinal vascular diseases with IIT-H. Brings together clinical ophthalmology, public health, and engineering expertise to tackle AMD, diabetic retinopathy, and ROP.
• CSIR-Centre for Cellular and Molecular Biology (CCMB)majorStrategic or Co-development Partner · 9 April 2026Collaborative study between CCMB and LVPEI uncovered alarming antimicrobial resistance in bacteria causing eye infections. Analyzed 291 patient samples collected over a year in Hyderabad. Study published in 'Communications Biology'. Researchers identified new AMR-associated mechanisms.
• Cole Eye Institute, ClevelandmajorStrategic or Co-development Partner · 5 April 2026Collaborative study with Cole Eye Institute (Cleveland) and ABO Eye Institute (Nagpur) on tubercular serpiginous-like choroiditis (TB-SLC), finding that approximately 18.5% of patients continued to exhibit inflammation even after completing standard anti-tubercular therapy.
• ABO Eye Institute, NagpurmajorStrategic or Co-development Partner · 5 April 2026Collaborative study with LVPEI and Cole Eye Institute on tubercular serpiginous-like choroiditis (TB-SLC).
• University of HyderabadmajorStrategic or Co-development Partner · 26 March 2026Collaborative study with University of Hyderabad identified two proteins (HIF1a and KAT2B) as potential biomarkers for retinoblastoma. Study published in Translational Vision Science and Technology.
• University of AlabamamajorStrategic or Co-development Partner · 10 February 2026Researchers from LVPEI and University of Alabama conducted collaborative study on mucormycosis (black fungus), examining eye and orbital tissues from 14 patients. Found that extremely high oxidative stress damaged cells and triggered multiple cell-death processes.
• Bose Institute, KolkatamajorStrategic or Co-development Partner · 2 February 2026Scientists from Bose Institute and LVPEI identified a novel antimicrobial peptide named SA-XV that could transform treatment of drug-resistant fungal infections of the cornea. Study published in Journal of Biological Chemistry, supported by Switzerland-based Velux Stiftung.
• Perkins IndiaminorStrategic or Co-development Partner · 26 August 2025Perkins India and LV Prasad Eye Institute presented plans to develop Capital Amaravati as a 'Model Inclusive City' aligned with UN Sustainable Development Goals.
• Liberia Ministry of HealthcoreStrategic or Co-development Partner · 26 August 2025Liberia Eye Center launched Liberia's first-ever nationwide RARE in collaboration with Liberia's Ministry of Health.
• JFK Medical Centre, MonroviacoreStrategic or Co-development Partner · 4 June 2025LVPEI-Liberia Eye Center is housed at JFK Medical Centre in Monrovia. Reached 10,000 surgeries milestone in May 2025. Half performed at no cost to patients.

Scale indicators18 records

Recent moves12 records

Expansion highlights7 records

Direct peers

• Aravind Eye Care System: India's largest non-profit eye hospital network, headquartered in Madurai, with a comparable cross-subsidization model and high surgical volumes. Directly comparable to LVPEI in mission, pyramidal care delivery, and clinical scale.
• Sankara Nethralaya: Non-profit eye hospital in Chennai providing comprehensive ophthalmic care, research and education with a similar cross-subsidization approach. Most direct Indian non-profit peer to LVPEI in terms of specialty focus and academic mission.
• Narayana Nethralaya: Multi-specialty eye hospital chain based in Bangalore with tertiary care, research, and training programs. Direct South-India peer in eye care delivery and clinical reputation.
• Tilganga Institute of Ophthalmology: Nepal-based WHO Collaborating Centre for eye care with a comparable non-profit mission, eye banking (Nepal Eye Bank), and international training programs. Closest international peer in mission and structure.

Broad incumbents

• Centre for Sight: Large for-profit Indian eye hospital chain operating across 80+ centers, offering comprehensive ophthalmology services. Represents the commercial, equity-backed alternative to LVPEI's non-profit model in the same specialty.
• Maxivision Eye Hospitals: For-profit, PE-backed Indian eye hospital chain expanding rapidly across South India. Competes with LVPEI for paying patients in metro and Tier-2 markets and represents the for-profit scaling benchmark.
• Apollo Hospitals (Ophthalmology Division): India's largest hospital chain operates ophthalmology departments across its network. A broad incumbent rather than a specialty player, but overlaps with LVPEI in tertiary eye surgery and emergency services.

Regional players

• ORBIS International: Global non-profit focused on preventing blindness through the Flying Eye Hospital and country-level capacity building, including India. Comparable in mission (global blindness prevention) and training focus, though operating model differs.

Others

• Sightsavers International: Global non-profit supporting eye health programs in 30+ countries and a long-standing LVPEI partner (Mudhole secondary center). Comparable in mission and donor base; operates as funder/partner rather than direct provider.
• DiagnosTear Technologies: Israeli/Israeli-Indian ophthalmic diagnostics company developing point-of-care tear-based diagnostics (TeaRx Red Eye); partnered with LVPEI for clinical trials. Represents a strategic commercialization partner rather than a peer, but adjacent in eye-care innovation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lvprasadeye
• Facebookfacebook.com/lvpei.india
• LinkedInlinkedin.com/company/lv-prasad-eye-institute-hyderabad

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about L V Prasad Eye Institute